David Baxter PhD
Late Founder
Another Tylenol Recall
By REED ABELSON, New York Times
March 29, 2011
It?s yet another recall from the makers of Tylenol.
McNeil Consumer Healthcare, a unit of Johnson & Johnson, announced Tuesday afternoon that it was recalling more of its over-the-counter Tylenol products. In a statement, the company said that it was conducting a voluntary consumer recall of one product lot of eight-hour extended-release caplets because of a ?musty or moldy odor.?
About 34,000 bottles are being recalled, according to a McNeil spokeswoman. The company says any health risk from the caplets is ?remote.?
The company also announced it was expanding a previous recall announced in January. Unlike the Tylenol caplet recall, the expanded recall, which involves 10 lots of other products, is being undertaken on the wholesale level and is not based on adverse events, according to the company.
About 718,000 bottles or packages of Tylenol, Benadryl and Sudafed products were involved in the recall. Here?s a complete list of affected products.
These are the latest recalls involving products made at a now-shuttered plant in Fort Washington, Pa., and they continue what some analysts see as a never-ending problem at Johnson & Johnson. The company has been plagued by manufacturing and quality problems in its popular over-the-counter medicines, including many of its children?s products, that forced the closure of one plant and an overhaul of its procedures.
As part of the process to try to address past issues and bring the closed plant up to federal standards, the company has been reviewing manufacturing records of over-the-counter drugs and recalling certain products as a result.
Earlier this month, Johnson & Johnson reached an agreement with federal regulators that imposes greater federal oversight of manufacturing of products made by its McNeil unit. Regulators said manufacturing processes failed to comply with federal law.
By REED ABELSON, New York Times
March 29, 2011
It?s yet another recall from the makers of Tylenol.
McNeil Consumer Healthcare, a unit of Johnson & Johnson, announced Tuesday afternoon that it was recalling more of its over-the-counter Tylenol products. In a statement, the company said that it was conducting a voluntary consumer recall of one product lot of eight-hour extended-release caplets because of a ?musty or moldy odor.?
About 34,000 bottles are being recalled, according to a McNeil spokeswoman. The company says any health risk from the caplets is ?remote.?
The company also announced it was expanding a previous recall announced in January. Unlike the Tylenol caplet recall, the expanded recall, which involves 10 lots of other products, is being undertaken on the wholesale level and is not based on adverse events, according to the company.
About 718,000 bottles or packages of Tylenol, Benadryl and Sudafed products were involved in the recall. Here?s a complete list of affected products.
These are the latest recalls involving products made at a now-shuttered plant in Fort Washington, Pa., and they continue what some analysts see as a never-ending problem at Johnson & Johnson. The company has been plagued by manufacturing and quality problems in its popular over-the-counter medicines, including many of its children?s products, that forced the closure of one plant and an overhaul of its procedures.
As part of the process to try to address past issues and bring the closed plant up to federal standards, the company has been reviewing manufacturing records of over-the-counter drugs and recalling certain products as a result.
Earlier this month, Johnson & Johnson reached an agreement with federal regulators that imposes greater federal oversight of manufacturing of products made by its McNeil unit. Regulators said manufacturing processes failed to comply with federal law.
